There are 55 new cases of COVID-19 to report in Saskatchewan on June 14, with no cases in the Weyburn area, bringing the provincial total to 47,996 cases.
The new cases are located in the following zones: Far North West, 1; Far North East, 1; Northwest, 4; North Central, 2; Saskatoon, 23; Central West, 3; Central East, 3; Regina, 12; Southwest, 2; South Central, 3; and Southeast, 1. One case with pending residence information was assigned to the Northwest zone.
One new death is being reported in the 80+ age group from the Saskatoon zone.
Recoveries total 46,666, including 89 new recoveries, and 774 cases are considered active.
There are 95 people in hospital, and 76 people are receiving inpatient care: Northwest, 10; North Central, 6; Saskatoon, 30; Central East, 4; Regina, 21; Southwest, 2; South Central, 1; and Southeast; 2. Nineteen people are in intensive care: Northwest, 2; North Central, 3; Saskatoon, 6; Central East, 1; Regina, 6; and Southwest, 1.
The seven-day average of new COVID-19 case number is 76 (6.2 per 100,000).
There were 1,691 COVID-19 tests processed in Saskatchewan on June 13, including 41 tests for the southeast region.
If just one per cent of Saskatchewan adults get their first COVID-19 vaccine shot in the next six days, the province will begin Step Three of its Re-Opening Roadmap on July 11.
Currently, 69 per cent of those 18 and older have now received their first dose.
If just three per cent of eligible Saskatchewan residents get their first COVID-19 vaccine shot in the next six days, the province will also lift all remaining public health restrictions on July 11.
Currently, 67 per cent of those 12 and older have now received their first dose.
An additional 9,928 doses of COVID-19 vaccine have been given in Saskatchewan, including 456 doses in the southeast region, bringing the total number of vaccines administered in the province to 903,442.
Seventy-nine per cent of those over the age of 40 have received their first dose, 73 per cent of those 30+ have received their first dose, 69 per cent of those 18+ have received their first dose, while 67 per cent of those 12+ have also received their first dose.
All residents 12+ can receive their first dose and second dose vaccinations are open to residents 50+ or anyone who received their first dose on or before April 15. Individuals diagnosed with or being treated for cancer and those who have received solid organ transplants will receive a letter of eligibility in the mail that will allow them priority access to a second dose.
When all persons 12 and older become eligible to receive their second doses starting June 24, vaccinations will be provided based on the manufacturer interval. For Moderna, this is 28 days after first dose. For Pfizer, this is 21 days after first dose. Note that residents may receive their second doses up to four months following their first dose but it's highly recommended that you receive your second dose as soon as you are eligible.
A limited number of first doses of AstraZeneca have been administered since May 5 to those individuals who have contraindication for mRNA vaccines. If you received AstraZeneca as recommended by your health care provider after May 5, arrangements will be made to administer your second dose based on current, recommended intervals.